Clinical use:

The safety and efficacy of QULIPTA in pediatric patients have not been studied.

Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range and maintained at the lowest effective dose, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Relevant warnings and precautions:

●Caution driving and operating machinery

●Avoid use in severe hepatic impairment

●Hypersensitivity reactions

●Geriatrics

●Pregnancy and breastfeeding

For more information:

Consult the Product Monograph for important information relating to adverse reactions, drug interactions, and dosing information. The Product Monograph is also available by calling 1-888-704-8271.